Thermo Fisher upgraded to Overweight from Neutral at JPMorgan JPMorgan upgraded Thermo Fisher citing an attractive risk/reward profile and the company's likely beatable guidance. The firm raised its price target for shares to $80 from $70.
News For TMO From The Last 14 Days
Check below for free stories on TMO the last two weeks.
Thermo Fisher to sell Cole-Palmer to GTCR for $480M in cash Thermo Fisher Scientific has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480M in cash. Thermo Fisher anticipates closing the transaction in Q3, subject to customary closing conditions and applicable regulatory approvals. The company expects an immaterial impact to 2014 adjusted EPS and will update annual guidance in its Q2 earnings release on July 23.